After the Internet fitness community began talking about an Ohio State University study that described relatively high injury rates among CrossFitters, the Russes mobilized. They had Glassman's father, Jeffrey Glassman (now "chief scientist" at CrossFit), write a comprehensive rebuttal to the study for the CrossFit website. Berger called each and every research subject who had been reported as injured, to conclude that none actually were hurt, and then added an entire stammering Q&A with one of the paper's authors, kinesiology professor Steven Devor. Here's the kicker: The actual subject of the study was the great improvements in fitness the researchers found in CrossFit athletes. Aside from a handful of sentences, it was all positive.
Book-lovin’ Whole30 eaters should also pick up a copy of my New York Times bestselling cookbook, Nom Nom Paleo: Food for Humans, and my follow-up recipe book, Ready or Not! Both are packed with new and classic recipes—many of which can’t be found anywhere else. Plus, the vast majority of them are Whole30-compliant! Here’s a downloadable list of the 100+ Whole30 recipes in my first book, and here’s the Recipe Index in my second book, which identifies the 120+ Whole30 friendly dishes contained in its pages.
Anti-inflammatory meal plan: 26 recipes to try For people with chronic inflammatory conditions, diet can have a powerful effect. Certain foods can help to reduce joint pain, stiffness, and other symptoms. These include omega-3s, antioxidants, and probiotics. In this article, we provide 26 anti-inflammatory recipes you can use in a healthful, nutritious meal plan. Read now
The WHO trial (so named because the international team of principal investigators contained World Health Organization members) tested the potential of clofibrate, a “pre-statin” cholesterol-lowering agent, to reduce heart attack morbidity and mortality. The investigators ultimately concluded that clofibrate "cannot be recommended as a lipid-lowering drug for community-wide primary prevention of ischaemic heart disease.” Nevertheless, clofibrate remained in use until 2002, when it was pulled for increasing cancer rates. In their review of studies such as the WHO trial, Uffe Ravnskov and David Diamond observe, “Despite the largely disappointing findings from 50 years of cholesterol lower[ing] trials, the indictment and conviction of cholesterol as the causal agent in CVD [cardiovascular disease] has stood the test of time. … [Yet] the grand effort to reduce cholesterol as a strategy to improve health has failed.”